CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 65 enrolled
Drug / intervention
synthetic monofilament polypropylene meshdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00475540
NCT00475540N/ACompleted

A Randomized Clinical Trial of Vaginal Mesh for Prolapse

Medstar Health Research Institute·interventional·Posted May 21, 2007·Updated Oct 12, 2022

In Brief

A clinical study evaluating synthetic monofilament polypropylene mesh for Pelvic Organ Prolapse and 4 related conditions. Completed, enrolled 65 participants across 1 site.

Detailed Summary

The primary aim of this double-blind, randomized clinical trial (RCT) is to test the hypothesis that the addition of a standardized technique of interpositional synthetic polypropylene mesh placement improves the one-year outcome of vaginal reconstructive surgery for pelvic organ prolapse compared to traditional vaginal reconstructive surgery without mesh.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 21, 2007
Enrollment StartJan 1, 2007
Primary CompletionAug 1, 2012
Study CompletionAug 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 19.1 years ago

Interventions

synthetic monofilament polypropylene meshdevice

Vaginal prolapse repair with mesh